Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Neurol Neurosurg Psychiatry. 2018 Oct 8;90(2):180–186. doi: 10.1136/jnnp-2018-318993

Figure 2.

Figure 2

Levels of sAPPβ, YKL–40 and the sAPPβ:YKL–40 ratio in cearbrospinal fluid across pathological diagnostic groups. Only statistically significant differences are displayed (analysis of covariance and post-hoc Tukey’s honest significant differences). All results were adjusted for age and sex, and correction for multiple comparisons was applied. AD, Alzheimer’s disease; FTLD-Tau, frontotemporal lobar degeneration-Tau; FTLD-TDP, frontotemporal lobar degeneration-TDP, sAPPβ, soluble β fragment of amyloid precursor protein.